News from GenomeDx Biosciences A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

25 Apr, 2017, 08:00 ET GenomeDx's Decipher Post-Op Demonstrates Positive Impact on Physician, Patient Treatment Decisions in Multicenter Prospective Study

GenomeDx Biosciences today announced the publication of interim results from an ongoing prospective clinical study of the impact of the Decipher®...


24 Mar, 2017, 08:00 ET GenomeDx's Decipher Tests and Decipher GRID to be Featured in Multiple Presentations at the 32nd Annual EAU Congress

GenomeDx Biosciences today announced that six abstracts featuring Decipher GRID® (Genomics Resource Information Database) and Decipher® Prostate...


02 Mar, 2017, 08:00 ET GenomeDx Biosciences Announces Initiation by Michigan Urological Surgery Improvement Collaborative (MUSIC) of Prospective, Randomized Clinical Study of Decipher

GenomeDx Biosciences today announced the initiation of a prospective, randomized controlled trial evaluating the utility of its Decipher® Prostate...


14 Feb, 2017, 08:00 ET GenomeDx's Decipher Prostate, GRID and Bladder Data to be Featured in Multiple Presentations at the 2017 Genitourinary Cancers Symposium

GenomeDx Biosciences today announced that oral and poster presentations featuring Decipher® Prostate Cancer Classifier tests, Genomics Resource...


01 Feb, 2017, 08:00 ET GenomeDx Announces Research Collaboration with Astellas to Identify Genomic Drivers of Patient Response to XTANDI® (enzalutamide) Capsules

GenomeDx Biosciences today announced that it has entered into a research collaboration with Astellas, a leading global pharmaceutical company, to...


25 Jan, 2017, 08:00 ET GenomeDx's Decipher Biopsy Demonstrates Ability to Predict Metastasis After Radiation and Androgen Deprivation Therapy in Prostate Cancer Patients

GenomeDx Biosciences today announced the first study that demonstrates the ability of the Decipher® Prostate Cancer Classifier Biopsy Test...


29 Nov, 2016, 08:00 ET GenomeDx's Decipher Prostate and Bladder Data to be Featured in Multiple Presentations at 17th Annual Meeting of the Society of Urologic Oncology

GenomeDx Biosciences today announced that ten presentations featuring Decipher® Prostate and Bladder data will be presented at the 17th...


19 Oct, 2016, 08:00 ET GenomeDx's Decipher GRID Aids in Development and Validation of the First Molecular Signature to Predict Response to Radiotherapy in Prostate Cancer

GenomeDx Biosciences today announced that gene expression profiles in the company's Decipher Genomics Resource Information Database (Decipher...


04 Oct, 2016, 08:00 ET GenomeDx and Bostwick Laboratories Announce Marketing Agreement for Decipher Prostate Cancer Classifier Test

 GenomeDx Biosciences and Bostwick Laboratories, Inc. today announced that Bostwick has entered into a marketing partnership agreement with...


29 Sep, 2016, 08:00 ET GenomeDx Launches Expanded GRID Tumor Profiling to Provide Enhanced Genomic Understanding of Patients' Prostate Cancer

 GenomeDx Biosciences today announced that it has launched an expanded version of its Decipher GRID® Tumor RNA Expression Profile, a...


28 Sep, 2016, 08:00 ET GenomeDx and SouthGenetics Announce Strategic Agreement for Latin America Commercialization

 GenomeDx Biosciences and SouthGenetics Inc. today announced that they have signed a strategic agreement to bring GenomeDx's Decipher®...


22 Sep, 2016, 08:00 ET GenomeDx's Decipher GRID and Decipher Tests to be Featured in Multiple Presentations at ASTRO 2016

 GenomeDx Biosciences today announced that eight presentations featuring Decipher Genomics Resource Information Database (Decipher GRID®)...


13 Sep, 2016, 08:00 ET GenomeDx Adds Multiple Leading Cancer Centers to Its Proprietary Genomics Resource Information Database Platform (Decipher GRID)

GenomeDx Biosciences today announced that it has expanded access to its Decipher Genomics Resource Information Database (Decipher GRID®) to a...


06 Sep, 2016, 08:00 ET Prospective Study Shows GenomeDx's Decipher Cancer Classifier Significantly Reclassifies Tumor Aggressiveness

GenomeDx Biosciences today announced the publication of the first prospective validation study for its Decipher® Prostate Cancer Classifier...


06 Jul, 2016, 08:00 ET GenomeDx Biosciences Receives Accreditation from College of American Pathologists

GenomeDx Biosciences, a leading provider of genomic solutions, today announced that it has received Laboratory Accreditation from the College of...


14 Jun, 2016, 08:00 ET GenomeDx's Decipher Platform Utilizes Gene Expression Signatures to Predict Lymph Node Metastasis in Bladder Cancer Patients

 GenomeDx Biosciences today announced that its Decipher GRIDTM platform was used to develop and validate a novel genomic signature, known as...


19 May, 2016, 08:00 ET Decipher Prostate Cancer Test Guides Timing of Postoperative Radiotherapy

GenomeDx Biosciences today announced the publication of a multi-institution validation study of the Decipher® Prostate Cancer Classifier, a...


09 May, 2016, 08:00 ET GenomeDx's Decipher Platform Identifies Gene Expression Associated with Resistance to Chemotherapy Treatment in Bladder Cancer

 GenomeDx Biosciences today announced that its Decipher® platform was used to evaluate molecular subtypes associated with resistance to...


28 Apr, 2016, 08:00 ET GenomeDx's Decipher GRID and Decipher Tests to be Featured in Multiple Abstracts at the 111th American Urological Association Annual Meeting

 GenomeDx Biosciences today announced that eight abstracts featuring Decipher Genomics Resource Information Database (Decipher GRID®) and...


15 Mar, 2016, 08:00 ET New Study Shows that Genetic Information from Prostate Needle Biopsy May Be Used to Predict Tumor Aggressiveness

 GenomeDx Biosciences today announced results from a new study which demonstrates the ability to measure and evaluate biomarkers from RNA...


08 Mar, 2016, 08:00 ET GenomeDx Biosciences Launches Decipher Biopsy Test

 GenomeDx Biosciences today announced the launch of Decipher Biopsy, a genomic test that evaluates RNA expression-based biomarkers to predict...


07 Mar, 2016, 08:00 ET GenomeDx's Decipher GRID and Decipher Biopsy to be Featured at the 31st Annual EAU Congress

GenomeDx Biosciences today announced that three abstracts featuring Decipher GRID (Genomics Resource Information Database) and Decipher Prostate...


04 Feb, 2016, 08:00 ET GenomeDx Publishes First Study Supporting Use of Decipher Test in Prostate Biopsy

GenomeDx Biosciences today announced publication of results that show Decipher Prostate Cancer Classifier, which is validated and commercially...


04 Jan, 2016, 08:00 ET GenomeDx's Decipher GRID™ and Decipher® Test to be Featured in Seven Presentations at 2016 Genitourinary Cancers Symposium

 GenomeDx Biosciences today announced that seven abstracts featuring the Decipher Genomic Resource Information Database (Decipher GRID™)...


02 Dec, 2015, 16:30 ET GenomeDx's Decipher GRID™ Evaluates New Biomarker for Prostate Cancer, Further Defines Utility of Decipher Prostate Cancer Test

 GenomeDx Biosciences today announced that data from two separate studies demonstrating the power of its Decipher Genomic Resource Information...